Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South

J Am Acad Nurse Pract. 2012 Aug;24(8):488-98. doi: 10.1111/j.1745-7599.2012.00712.x. Epub 2012 Apr 30.

Abstract

Purpose: Strict adherence to HIV medications is critical to ensure long-term disease control, and adherence interventions that are possible in a clinic setting with limited resources are needed.

Data sources: This randomized controlled pilot study tested an adherence intervention guided by the Information-Motivation-Behavioral Skills (IMB) model. The intervention included HIV education, a peer video, motivational interviewing, and attention to behavioral skills including communication with providers and adherence-enhancing devices. Dependent variables included 3-4 week adherence recall, medication refill rate, changes in IMB subscale scores, appointment attendance, and HIV-associated laboratory findings. Seventy-three individuals starting or restarting antiretroviral therapy were enrolled and 56 were randomized.

Conclusions: Improvements were seen in most outcomes, with small to moderate effect sizes, but the study was not powered to show statistical significance. Threats to power included a 51% attrition rate, resulting mostly from loss to clinical care or prolonged gaps in care.

Implications for practice: A telephone-based intervention to improve HIV medication adherence shows promise. Further study is needed with greater attention to retention in care.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Analysis of Variance
  • Anti-HIV Agents / therapeutic use*
  • Behavioral Medicine*
  • Community Health Services*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / nursing
  • HIV Infections / psychology
  • Health Literacy
  • Humans
  • Interview, Psychological
  • Male
  • Medication Adherence*
  • Mississippi
  • Models, Psychological
  • Motivation
  • Psychometrics
  • Self Report
  • Surveys and Questionnaires

Substances

  • Anti-HIV Agents